The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

NACompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1992

Primary Completion Date

November 30, 1994

Study Completion Date

November 30, 1994

Conditions
Mycobacterium Avium-intracellular InfectionHIV Infections
Interventions
DRUG

Clarithromycin

Trial Locations (22)

10011

Saint Vincent's Hosp and Med Ctr, New York

10595

New York Med College / Westchester County Med Ctr, Valhalla

13210

SUNY / Health Sciences Ctr at Syracuse, Syracuse

24153

Salem Veterans Administration Med Ctr, Salem

28207

Nalle Clinic, Charlotte

33021

Dr Nelson Zide, Hollywood

33308

TheraFirst Med Ctrs Inc, Fort Lauderdale

33614

Infectious Disease Research Institute Inc, Tampa

37212

Vanderbilt Univ, Nashville

38163

Univ of Tennessee, Memphis

46202

Indiana Univ Hosp, Indianapolis

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

77030

Houston Veterans Administration Med Ctr, Houston

78284

Audie L Murphy Veterans Administration Hosp, San Antonio

85724

Univ of Arizona / Health Science Ctr, Tucson

92102

HIV Research Group, San Diego

93726

California Med Research Group, Fresno

94109

Saint Francis Mem Hosp, San Francisco

94115

Kaiser Permanente Med Ctr, San Francisco

97210

Westover Heights Clinic, Portland

98405

Dr Alan D Tice / Infections Ltd, Tacoma

951282699

Santa Clara Valley Med Ctr, San Jose

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY